XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026)
XOMA Royalty's (XOMA) quarterly Depreciation & Amortization - Total came in at $3000.0 in Q1 2026, little changed year-on-year from $3000.0 in Q1 2025, and little changed quarter-over-quarter from $3000.0 in Q4 2025.
XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026) Analysis & Trends
XOMA Royalty has disclosed Depreciation & Amortization - Total across 3 years of filings, most recently posting $3000.0 for Q1 2026.
- Depreciation & Amortization - Total for Q1 2026 came in at $3000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $11000.0 (changed 0.0% YoY), and the FY2025 annual result was $11000.0, up 10.0% from the prior year.
- Depreciation & Amortization - Total came in at $3000.0 for Q1 2026 at XOMA Royalty, roughly flat from $3000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization - Total ranged from a high of $3000.0 in Q2 2024 to a low of $2000.0 in Q1 2024.
- The 3-year median for Depreciation & Amortization - Total is $3000.0 (2024), against an average of $2666.7.
- Peak annual rise in Depreciation & Amortization - Total reached 50.0% in 2025, while the deepest fall reached 33.33% in 2025.
- XOMA Royalty's Depreciation & Amortization - Total stood at $2000.0 in 2024, then surged by 50.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- The last three Depreciation & Amortization - Total figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $2000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | XOMA Royalty | 5.48 Mn | -60.60 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |